KALA


Key FDA Decisions Could Power These 3 Biopharma Stocks

Today, we list 3 biopharma companies that have FDA events approaching along with positive analyst sentiment. In other words, analysts expect these companies’ …

Wedbush Sees 240% Upside for Kala Pharmaceuticals (KALA) Stock; Here’s Why

Wedbush analyst Liana Moussatos is out today with a bullish note on shares of Kala Pharmaceuticals (NASDAQ:KALA), following the drug maker’s announcement that it plans to …